HCC: The role of immunotherapy beyond advanced HCC

December 06, 2023 00:29:42
HCC: The role of immunotherapy beyond advanced HCC
COR2ED - Oncology Medical Conversation
HCC: The role of immunotherapy beyond advanced HCC

Dec 06 2023 | 00:29:42

/

Show Notes

In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional therapy for advanced and early stage hepatocellular carcinoma (HCC).  They focus on the role of immunotherapy and review data from three major congresses in 2022 (ASCO, WCGIC and ILC) together with recent publications. 

Prof. Amit Singal is Director of Liver Cancer Program at UT Southwestern Medical Center, Dallas, TX, USA and Assoc. Prof. Neil Mehta is Director of Liver Cancer Program at University of California San Francisco, USA.

Other Episodes

Episode

December 06, 2023 00:26:43
Episode Cover

Prostate cancer: PARP inhibitors in prostate cancer

COR2ED Medical Education: Dr Jason Alcorn, nurse consultant for Uro-Oncology & Andrology at the Mid Yorkshire Hospitals NHS Trust, United Kingdom and Dr Alicia...

Listen

Episode

April 15, 2025 00:21:27
Episode Cover

The HER2 Diagnostic and Treatment Landscape in NSCLC

Episode 1: Identifying HER2-directed NSCLC: The Medical Oncologist and Pathologist perspectives  This is the first episode of a two-part series on the HER2 diagnostic...

Listen

Episode

September 11, 2024 00:22:51
Episode Cover

Neuroendocrine tumours (NETs) – Shared decision-making. Part 2: Individualising treatment decisions

In this second episode of a two-part podcast series focusing on neuroendocrine tumours (NETs), gastroenterologist Dr Mohid S Khan and NET patient Sally Jenkins...

Listen